SexyMD Tirzepatide Review: $369 a Month, $299 at 48 Weeks (2026)

SexyMD charges $369 a month for compounded tirzepatide on its four-week plan, and that rate is on the product page before any intake. Every headline on the site quotes $299, which is the 48-week commitment rate rather than the standing one. Everything below was read live on 1 September 2026.¹

The ladder, and why it makes the headline checkable

The whole commitment ladder is published with each term labeled, which is what makes the headline checkable without arithmetic: $369 at four weeks, $349 at twelve, $329 at twenty-four and $299 at forty-eight. The bottom two rungs are marked Delivered every 12 weeks, so their per-month figure is an average across a quarterly shipment rather than a monthly charge. What the price covers — consult, shipping, supplies, dose escalation — is itemized on no product page.

The microdose pages and the numbers around the checkout

The two microdose products publish identical prices for four, eight and twelve weeks, in the same table format that carries real tiers on the full-dose pages. The microdose page then contradicts itself on dosing frequency, promising twice-weekly injections in the body copy and once weekly in the instructions. Three unsourced and mutually inconsistent review counts run across the site, and the checkout claims 27,810 patients chose a plan in a single day on a site whose own badge reads loved by 800+ women. The asterisk beside the companion "as low as $199/mo*" headline resolves to no footnote anywhere.

Who is named, and where the footer argues with itself

SexyMD LLC is named as a Nevada limited liability company with a Las Vegas address, in the footer and the Terms alike. Two professional entities are named behind the prescriptions, WizDoc LLC and Jonathan Larson, MD, P.C., and the Terms state the pharmacy classes used: 503A pharmacies and 503B outsourcing facilities. No individual pharmacy is named, and prescriptions may be routed or transferred among them without notice. The same footer block, on every page read, says both "available in all 50 states" and "available in all states except Arkansas, Mississippi, and New Jersey."

The brand-vs-compounded question

This is compounded tirzepatide, sold as "Compounded GLP-1 + GIP Injections" — the product pages never name the molecule, and the mapping comes from the Terms and from the intake's own code. Compounded drugs are pharmacy-made, are not FDA-approved finished products, and were not what the pivotal trials tested. Our guide to whether compounded tirzepatide is still legal in 2026 covers where that stands, and tirzepatide microdosing covers the lower-dose pitch.

How the care model holds up

The strengths are the published ladder, the named entity and the stated pharmacy classes. The weaknesses cluster around what happens after you pay. There is no general right of refund once clinical review has begun, cancellation must land at least 48 hours before a renewal date, and the Terms defer the quarterly tiers' charge amount to checkout.

Does the drug work? (Separate from the provider)

Price and disclosure are the seller's problem; efficacy is the molecule's. Tirzepatide's evidence is unusually strong: roughly 15% to 21% of body weight over 72 weeks in SURMOUNT-1², and a decisive result against semaglutide in the head-to-head SURMOUNT-5³. Those trials used the branded drug at approved doses, not a compounded copy, and our tirzepatide evidence guide sets out what transfers and what does not.

The honest verdict

Budget $369 unless you are ready to sign up for 48 weeks, and give SexyMD credit for printing the ladder that proves the gap. If you want that lower number without the commitment, Alinwell charges $299 every 30 days and publishes certificates of analysis naming two compounding pharmacies with street addresses. If a quarterly plan suits you, VevaRX sells tirzepatide only as a $467 charge every three months, a different bargain rather than a cheaper one. The rest of the field is ranked in our best tirzepatide providers list.